<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26728">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01892215</url>
  </required_header>
  <id_info>
    <org_study_id>MHST2012-08</org_study_id>
    <nct_id>NCT01892215</nct_id>
  </id_info>
  <brief_title>Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad,</brief_title>
  <official_title>Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad. A Randomized, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Thomas Hospital, Panama</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Thomas Hospital, Panama</source>
  <oversight_info>
    <authority>Panama: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstetrical blood loss is an important reason of maternal morbidity and mortality. Because
      of the increase in the rate of cesarean section, any procedure that could help reduce blood
      loss during cesarean section should be investigated.  The purpose of this study was to
      compare 2 methods of blunt expansion of the uterine incision at the time of cesarean
      delivery: transversal vs. cephalad-caudad.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Blood loss (hemoglobin level)</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Difference in hemoglobin level between 24 hours pre-surgery and the hemoglobin level before leaving the hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of cases of surgical complications (hematomas, unintended extension of the uterine incision, need for transfusion) between the two techniques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unintented extension of uterine incision</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of cases of unintended extension of the uterine incision during surgery between the two techniques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematoma formation</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of cases of hematoma formation during or after between the two techniques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for transfusion</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of cases that required a blood transfusion between the two techniques.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">839</enrollment>
  <condition>Blunt Expansion of the Uterine Incision.</condition>
  <arm_group>
    <arm_group_label>Cephalad-caudad</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blunt expansion of the uterine incision by the physician separating the fingers in a cephalad-caudad direction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transversal expansion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blunt expansion of the uterine incision by the physician separating the fingers in a transversal direction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cephalad-caudad expansion</intervention_name>
    <description>Blunt expansion of the uterine incision by the physician separating the fingers in a cephalad-caudad direction.</description>
    <arm_group_label>Cephalad-caudad</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transversal expansion</intervention_name>
    <description>Blunt expansion of the uterine incision by the physician separating the fingers in a transversal direction.</description>
    <arm_group_label>Transversal expansion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancies

          -  Gestational age: 34 weeks or more

          -  Delivery by cesarean section

          -  Presurgical hemoglobin &gt; 10.5 g/dL

        Exclusion Criteria:

          -  Two or more previous cesarean sections

          -  History of uterine rupture in a previous pregnancy

          -  History of myomectomy

          -  History of abdominal trauma with an uterine lesion

          -  Blood dyscrasia

          -  Multiple pregnancy

          -  Placenta previa

          -  Abruptio placenta

          -  Stillbirth

          -  Sharp uterine expansion
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osvaldo Reyes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Thomas Maternity Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Morales, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Thomas Maternity Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint Thomas Maternity Hospital</name>
      <address>
        <city>Panama</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 30, 2013</lastchanged_date>
  <firstreceived_date>June 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint Thomas Hospital, Panama</investigator_affiliation>
    <investigator_full_name>Osvaldo A. Reyes T.</investigator_full_name>
    <investigator_title>Coordinator of Research</investigator_title>
  </responsible_party>
  <keyword>Uterine incision.</keyword>
  <keyword>Blunt transversal expansion.</keyword>
  <keyword>Blunt cephalad-caudad expansion.</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
